Mechanisms underlying latent disease risk associated with early-life arsenic exposure: Current research trends and scientific gaps

Environmental Health Perspectives

Volumn 124, Issue 2, 2016, Pages 170-175

  Bailey, Kathryn A ^a   Smith, Allan H ^b   Tokar, Erik J ^c   Graziano, Joseph H ^d   Kim, Kyoung Woong ^e   Navasumrit, Panida ^f   Ruchirawat, Mathuros ^f   Thiantanawat, Apinya ^f   Suk, William A ^c   Fry, Rebecca C ^a  

^a The University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d Mailman School of Public Health   (United States)

^e Gwangju Institute of Science and Technology (GIST)   (South Korea)

^f Toxicology and Management of Chemicals   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CD34 ANTIGEN; DRINKING WATER; ESTROGEN RECEPTOR ALPHA; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; WATER POLLUTANT;

ARTICLE; ATHEROSCLEROSIS; CANCER RISK; CANCER STEM CELL; CARCINOGENESIS; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; ADOLESCENT; ADULT; AGED; ANIMAL; CHEMICALLY INDUCED; CHILD; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; INFANT; MIDDLE AGED; NEOPLASM; NEWBORN; PRESCHOOL CHILD; RISK FACTOR; TOXICITY; VERY ELDERLY; WATER POLLUTANT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARSENIC; CHILD; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; DRINKING WATER; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; NEOPLASMS; RISK FACTORS; WATER POLLUTANTS, CHEMICAL; YOUNG ADULT;

EID: 84956617044     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1409360     Document Type: Article

References (82)

1. Ahmed S, Mahabbat-e Khoda S, Rekha RS, Gardner RM, Ameer SS, Moore S, et al. 2011. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ Health Perspect 119:258-264; doi:10.1289/ehp.1002086.
2. Bailey KA, Laine J, Rager JE, Sebastian E, Olshan A, Smeester L, et al. 2014. Prenatal arsenic exposure and shifts in the newborn proteome: interindividual differences in tumor necrosis factor (TNF)-responsive signaling. Toxicol Sci 139:328-337.
3. Bollati V, Baccarelli A. 2010. Environmental epigenetics. Heredity (Edinb) 105:105-112.
4. Broberg K, Ahmed S, Engström K, Hossain MB, Jurkovic Mlakar S, Bottai M, et al. 2014. Arsenic exposure in early pregnancy alters genome-wide DNA methylation in cord blood, particularly in boys. J Dev Orig Health Dis 5:288-298.
5. Cannon RE, Spalding JW, Virgil KM, Faircloth RS, Humble MC, Lacks GD, et al. 1998. Induction of transgene expression in Tg.AC (v-Ha-ras) transgenic mice concomitant with DNA hypomethylation. Mol Carcinog 21:244-250.
6. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF III, Petraglia F. 2009. Inflammation and pregnancy. Reprod Sci 16:206-215.
7. Cosentino F, Egidy Assenza GE. 2004. Diabetes and Inflammation. Herz 29:749-759.
8. Cottingham KL, Karimi R, Gruber JF, Zens MS, Sayarath V, Folt CL, et al. 2013. Diet and toenail arsenic concentrations in a New Hampshire population with arsenic-containing water. Nutr J 12:149; doi:10.1186/1475-2891-12-149.
9. Cronican AA, Fitz NF, Carter A, Saleem M, Shiva S, Barchowsky A, et al. 2013. Genome-wide alteration of histone H3K9 acetylation pattern in mouse offspring prenatally exposed to arsenic. PloS One 8:e53478; doi:10.1371/journal.pone.0053478.
10. Dangleben NL, Skibola CF, Smith MT. 2013. Arsenic immunotoxicity: a review. Environ Health 12:73; doi:10.1186/1476-069X-12-73.
11. Davis MA, Mackenzie TA, Cottingham KL, Gilbert-Diamond D, Punshon T, Karagas MR. 2012. Rice consumption and urinary arsenic concentrations in U.S. children. Environ Health Perspect 120:1418-1424; doi:10.1289/ehp.1205014.
12. DeWitt JC, Peden-Adams MM, Keil DE, Dietert RR. 2012. Current status of developmental immunotoxicity: early-life patterns and testing. Toxicol Pathol 40:230-236.
13. EFSA (European Food Safety Authority). 2009. Scientific opinion on arsenic in food. EFSA Panel on Contaminants in the Food Chain (CONTAM). EFSA J 12:1351.
14. Farzan SF, Karagas MR, Chen Y. 2013a. In utero and early life arsenic exposure in relation to long-term health and disease. Toxicol Appl Pharmacol 272:384-390.
15. Farzan SF, Korrick S, Li Z, Enelow R, Gandolfi AJ, Madan J, et al. 2013b. In utero arsenic exposure and infant infection in a United States cohort: a prospective study. Environ Res 126:24-30; doi:10.1016/j.envres.2013.05.001.
16. Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, et al. 2007. Activation of inflammation/NF-κB signaling in infants born to arsenicexposed mothers. PLoS Genet 3:e207; doi:10.1371/journal.pgen.0030207.
17. Garcia-Esquinas E, Pollán M, Umans JG, Francesconi KA, Goessler W, Guallar E, et al. 2013. Arsenic exposure and cancer mortality in a US-based prospective cohort: the Strong Heart Study. Cancer Epidemiol Biomarkers Prev 22:1944-1953.
18. Garelick H, Jones H, Dybowska A, Valsami-Jones E. 2008. Arsenic pollution sources. Rev Environ Contam Toxicol 197:17-60.
19. George CM, Smith AH, Kalman DA, Steinmaus CM. 2006. Reverse osmosis filter use and high arsenic levels in private well water. Arch Environ Occup Health 61:171-175.
20. Gilbert-Diamond D, Li Z, Perry AE, Spencer SK, Gandolfi AJ, Karagas MR. 2013. A population-based case-control study of urinary arsenic species and squamous cell carcinoma in New Hampshire, USA. Environ Health Perspect 121:1154-1160; doi:10.1289/ehp.1206178.
21. IARC (International Agency for Research on Cancer). 2012. Arsenic, metals, fibres and dusts. Arsenic and arsenic compounds. IARC Monogr Eval Carciong Risk Hum 100C:41-93.
22. Intarasunanont P, Navasumrit P, Waraprasit S, Chaisatra K, Suk WA, Mahidol C, et al. 2012. Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Environ Health 11:31; doi:10.1186/1476-069X-11-31.
23. Iredale JP. 2007. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117:539-548.
24. Jirtle RL, Skinner MK. 2007. Environmental epigenomics and disease susceptibility. Nature Rev Genet 8:253-262.
25. Karagas MR. 2010. Arsenic-related mortality in Bangladesh [Comment]. Lancet 376:213-214.
26. Kile ML, Baccarelli A, Hoffman E, Tarantini L, Quamruzzaman Q, Rahman M, et al. 2012. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect 120:1061-1066; doi:10.1289/ehp.1104173.
27. Kile ML, Houseman EA, Baccarelli AA, Quamruzzaman Q, Rahman M, Mostofa G, et al. 2014. Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics 9:774-782.
28. Koestler DC, Avissar-Whiting M, Houseman EA, Karagas MR, Marsit CJ. 2013. Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero. Environ Health Perspect 121:971-977; doi:10.1289/ehp.1205925.
29. Libby P, Ridker PM, Maseri A. 2002. Inflammation and atherosclerosis. Circulation 105:1135-1143.
30. Liu J, Xie Y, Ward JM, Diwan BA, Waalkes MP. 2004. Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Toxicol Sci 77:249-257.
31. Mazumder DN, Steinmaus C, Bhattacharya P, von Ehrenstein OS, Ghosh N, Gotway M, et al. 2005. Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology 16:760-765.
32. Mukherjee A, Sengupta MK, Hossain MA, Ahamed S, Das B, Nayak B, et al. 2006. Arsenic contamination in groundwater: a global perspective with emphasis on the Asian scenario. J Health Popul Nutr 24:142-163.
33. Nadeau KC, Li Z, Farzan S, Koestler D, Robbins D, Fei DL, et al. 2014. In utero arsenic exposure and fetal immune repertoire in a US pregnancy cohort. Clin Immunol 155:188-197.
34. National Research Council. 2001. Arsenic in the Drinking Water: 2001 Update. Washington, DC:National Academy Press.
35. Parvez F, Chen Y, Yunus M, Olopade C, Segers S, Slavkovich V, et al. 2013. Arsenic exposure and impaired lung function. Findings from a large population-based prospective cohort study. Am J Respir Crit Care Med 188:813-819.
36. Pilsner JR, Hall MN, Liu X, Ilievski V, Slavkovich V, Levy D, et al. 2012. Influence of prenatal arsenic exposure and newborn sex on global methylation of cord blood DNA. PloS One 7:e37147; doi:10.1371/journal.pone.0037147.
37. Prüss-Üstün A, Bos R, Gore F, Bartram J. 2008. Safer Water, Better Health: Costs, Benefits and Sustainability of Interventions to Protect and Promote Health. Geneva:World Health Organization, Geneva. Available: http://apps.who.int/iris/bitstream/10665/43840/1/9789241596435_eng.pdf [accessed 25 February 2015].
38. Rager JE, Bailey KA, Smeester L, Miller SK, Parker JS, Laine JE, et al. 2014. Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood. Environ Mol Mutagen 55:196-208.
39. Rahman A, Persson LA, Nermell B, El Arifeen S, Ekström EC, Smith AH, et al. 2010. Arsenic exposure and risk of spontaneous abortion, stillbirth, and infant mortality. Epidemiology 21:797-804.
40. Rahman A, Vahter M, Ekström EC, Persson LÅ. 2011. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ Health Perspect 119:719-724; doi:10.1289/ehp.1002265.
41. Rahman A, Vahter M, Ekström EC, Rahman M, Golam Mustafa AH, Wahed MA, et al. 2007. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am J Epidemiol 165:1389-1396.
42. Rahman MM, Ng JC, Naidu R. 2009. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ Geochem Health 31(suppl 1):189-200.
43. Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque AM, et al. 2009. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett 185:197-202.
44. Ravenscroft P, Brammer H, Richards KS. 2009. Arsenic Pollution: A Global Synthesis. Malden, MA:Wiley-Blackwell.
45. Recio-Vega R, Gonzalez-Cortes T, Olivas-Calderon E, Lantz RC, Gandolfi AJ, Alba CG. 2015. In utero and early childhood exposure to arsenic decreases lung function in children. J Appl Toxicol 35:358-366.
46. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. 2010. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49:1603-1616.
47. Rojas D, Rager JE, Smeester L, Bailey KA, Drobná Z, Rubio-Andrade M, et al. 2015. Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci 143:97-106.
48. Sanders AP, Messier KP, Shehee M, Rudo K, Serre ML, Fry RC. 2012. Arsenic in North Carolina: public health implications. Environ Int 38:10-16.
49. Sanders AP, Smeester L, Rojas D, DeBussycher T, Wu MC, Wright FA, et al. 2014. Cadmium exposure and the epigenome: exposure-associated patterns of DNA methylation in leukocytes from mother-baby pairs. Epigenetics 9:212-221.
50. Sen P, Biswas T. 2013. Arsenic: the largest mass poisoning of a population in history. BMJ 346:f3625; doi:10.1136/bmj.f3625.
51. Sesti F, Tsitsilonis OE, Kotsinas A, Trougakos IP. 2012. Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis. In Vivo 26:395-402.
52. Smith AH, Lingas EO, Rahman M. 2000. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ 78:1093-1103.
53. Smith AH, Marshall G, Liaw J, Yuan Y, Ferreccio C, Steinmaus C. 2012. Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ Health Perspect 120:1527-1531; doi:10.1289/ehp.1104867.
54. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, et al. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect 114:1293-1296; doi:10.1289/ehp.8832.
55. Smith AH, Steinmaus CM. 2009. Health effects of arsenic and chromium in drinking water: recent human findings. Annu Rev Public Health 30:107-122.
56. Smith AH, Yunus M, Khan AF, Ercumen A, Yuan Y, Smith MH, et al. 2013. Chronic respiratory symptoms in children following in utero and early life exposure to arsenic in drinking water in Bangladesh. Int J Epidemiol 42:1077-1086.
57. Soto-Peña GA, Luna AL, Acosta-Saavedra L, Conde P, López-Carrillo L, Cebrián ME, et al. 2006. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J 20:779-781.
58. Srivastava S, D’Souza SE, Sen U, States JC. 2007. In utero arsenic exposure induces early onset of atherosclerosis in ApoE-/- mice. Reprod Toxicol 23:449-456.
59. States JC, Singh AV, Knudsen TB, Rouchka EC, Ngalame NO, Arteel GE, et al. 2012. Prenatal arsenic exposure alters gene expression in the adult liver to a proinflammatory state contributing to accelerated atherosclerosis. PloS One 7:e38713; doi:10.1371/journal.pone.0038713.
60. Steinmaus C, Ferreccio C, Acevedo J, Yuan Y, Liaw J, Durán V, et al. 2014. Increased lung and bladder cancer incidence in adults after in utero and earlylife arsenic exposure. Cancer Epidemiol Biomarkers Prev 23:1529-1538.
61. Tokar EJ, Diwan BA, Waalkes MP. 2010a. Arsenic exposure in utero and nonepidermal proliferative response in adulthood in Tg.AC mice. Int J Toxicol 29:291-296.
62. Tokar EJ, Qu W, Liu J, Liu W, Webber MM, Phang JM, et al. 2010b. Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst 102:638-649.
63. Tokar EJ, Qu W, Waalkes MP. 2011. Arsenic, stem cells, and the developmental basis of adult cancer. Toxicol Sci 120(suppl 1):S192-S203.
64. Uddin R, Huda NH. 2011. Arsenic poisoning in Bangladesh. Oman Med J 26:207; doi:10.5001/omj.2011.51.
65. Vahter ME. 2007. Interactions between arsenic-induced toxicity and nutrition in early life. J Nutr 137:2798-2804.
66. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40.
67. Vega L, Soto G, Luna A, Acosta L, Conde P, Cebrián M, et al. 2009. Early signs of immunodepression induced by arsenic in children. In: Natural Arsenic in Groundwaters of Latin America (Bundschuh J, Armienta MA, Bhattacharya P, Matschullat J, Birkle P, Rodríguez R, eds). Boca Raton, FL:CRC Press, 435-446.
68. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. 2011. Natural innate and adaptive immunity to cancer. Ann Rev Immunol 29:235-271.
69. Waalkes MP, Liu J, Chen H, Xie Y, Achanzar WE, Zhou YS, et al. 2004a. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Natl Cancer Inst 96:466-474.
70. Waalkes MP, Liu J, Germolec DR, Trempus CS, Cannon RE, Tokar EJ, et al. 2008. Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res 68:8278-8285.
71. Waalkes MP, Liu J, Ward JM, Diwan BA. 2004b. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice. Toxicol Appl Pharmacol 198:377-384.
72. Waalkes MP, Liu J, Ward JM, Diwan BA. 2006a. Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. Toxicol Appl Pharmacol 215:295-305.
73. Waalkes MP, Liu J, Ward JM, Powell DA, Diwan BA. 2006b. Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res 66:1337-1345.
74. Waalkes MP, Ward JM, Diwan BA. 2004c. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25:133-141.
75. Waalkes MP, Ward JM, Liu J, Diwan BA. 2003. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol 186:7-17.
76. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, Kline J, et al. 2007. Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect 115:285-289; doi:10.1289/ehp.9501.
77. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, et al. 2004. Water arsenic exposure and children’s intellectual function in Araihazar, Bangladesh. Environ Health Perspect 112:1329-1333; doi:10.1289/ehp.6964.
78. WHO (World Health Organization). 2011. Guidelines for Drinking Water Quality, 4th Edition, 2011. Geneva, Switzerland. http://www.who.int/water_sanitation_health/publications/2011/dwq_chapters/en/ [accessed 2 February 2015].
79. Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, et al. 2007. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology 236:7-15.
80. Xu Y, Tokar EJ, Sun Y, Waalkes MP. 2012. Arsenictransformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype. Environ Health Perspect 120:865-871; doi:10.1289/ehp.1204987.
81. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Liaw J, Bates M, et al. 2010. Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Epidemiology 21:103-108.
82. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, et al. 2007. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol 166:1381-1391.